Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Geelen

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Acta Cardiologica|January 1, 1995
Radiofrequency ablation of atrioventricular node reentrant tachycardia: experience in 302 patientsG Fenelon, L Elvas, A D'avila, et al.
Shock (Augusta, Ga.)|December 23, 2004
Plasma vascular endothelial growth factor in severe sepsisMichiel van der Flier, Henk J van Leeuwen, Kok P van Kessel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinomaJ Wils, G Blijham, A Naus, et al.
The American Journal of Cardiology|February 15, 1992
Identification of patients at high risk for recurrence of sustained ventricular tachycardia after healing of acute myocardial infarctionL M Rodriguez, R Oyarzun, J Smeets, et al.
European Journal of Haematology|July 19, 2017
Influence of WHO versus ELN advanced phase chronic myeloid leukemia definitions on overall survivalInge G P Geelen, Noortje Thielen, Jeroen J W M Janssen, et al.
The Pediatric Infectious Disease Journal|January 25, 2003
Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitorsAnnemarie M Van Rossum, Menno I Gaakeer, Swenda Verweel, et al.
Infection and Immunity|August 24, 1999
Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor HC Neeleman, S P Geelen, P C Aerts, et al.
Antiviral Therapy|February 3, 2012
Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patientsRoos E Barth, Susan C Aitken, Hugo Tempelman, et al.
Leukemia|May 11, 2018
Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patientsInge G P Geelen, Fredrik Sandin, Noortje Thielen, et al.
Leukemia & Lymphoma|November 12, 2022
Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The NetherlandsGeneviève I C G Ector, Inge G P Geelen, Avinash G Dinmohamed, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Acta Cardiologica|January 1, 1995
Radiofrequency ablation of atrioventricular node reentrant tachycardia: experience in 302 patientsG Fenelon, L Elvas, A D'avila, et al.
Shock (Augusta, Ga.)|December 23, 2004
Plasma vascular endothelial growth factor in severe sepsisMichiel van der Flier, Henk J van Leeuwen, Kok P van Kessel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinomaJ Wils, G Blijham, A Naus, et al.
The American Journal of Cardiology|February 15, 1992
Identification of patients at high risk for recurrence of sustained ventricular tachycardia after healing of acute myocardial infarctionL M Rodriguez, R Oyarzun, J Smeets, et al.
European Journal of Haematology|July 19, 2017
Influence of WHO versus ELN advanced phase chronic myeloid leukemia definitions on overall survivalInge G P Geelen, Noortje Thielen, Jeroen J W M Janssen, et al.
The Pediatric Infectious Disease Journal|January 25, 2003
Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitorsAnnemarie M Van Rossum, Menno I Gaakeer, Swenda Verweel, et al.
Infection and Immunity|August 24, 1999
Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor HC Neeleman, S P Geelen, P C Aerts, et al.
Antiviral Therapy|February 3, 2012
Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patientsRoos E Barth, Susan C Aitken, Hugo Tempelman, et al.
Leukemia|May 11, 2018
Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patientsInge G P Geelen, Fredrik Sandin, Noortje Thielen, et al.
Leukemia & Lymphoma|November 12, 2022
Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The NetherlandsGeneviève I C G Ector, Inge G P Geelen, Avinash G Dinmohamed, et al.
Pageof 9